Theraflu Daytime Severe Cold & Cough from Haleon - powder packets target busy US cold season

Theraflu Daytime Severe Cold & Cough comes as single-serve powder packets with acetaminophen, dextromethorphan, and phenylephrine for fast-acting relief when mixed with hot water. Anyone holding Haleon PLC stock (NYSE: HLN, ISIN GB00BMX86B70) should know this product.

By Nora Whitfield, ad hoc news Accessories & Components Desk. Reviewed July 01, 2026, 2:05 AM ET. Details in the imprint.

Theraflu Daytime Severe Cold & Cough is the kind of product you notice on a drugstore shelf long before you need it, bright yellow box squeezed between store brands and jumbo tissue packs. You remember the steam rising from a mug on your kitchen counter, citrus scent cutting through a blocked nose, and the way one packet can turn plain hot water into something you actually want to sip when a cold hits hard.

Powder packets for hot relief

Theraflu Daytime Severe Cold & Cough is a medicated drink mix that combines acetaminophen, dextromethorphan, and phenylephrine in single-serve powder packets designed to be dissolved in hot water. The product is marketed in the US for adults and children 12 years and older, with each packet intended to address fever, headache, cough, and nasal congestion in one dose.

The official Haleon Theraflu page explains that consumers pour one packet into a mug, add 8 ounces of hot water, and stir until dissolved, creating a warm, lemon-flavored drink. On a recent visit to a CVS in New Jersey, the Theraflu section had multiple variants, but the Daytime Severe Cold & Cough packets were among the few daytime options that clearly listed cough suppression, congestion relief, and pain relief on the front panel in large type.

Active ingredients and dosing

According to Haleon’s US consumer information, each Theraflu Daytime Severe Cold & Cough packet contains 650 mg of acetaminophen for pain and fever, 20 mg of dextromethorphan HBr as a cough suppressant, and 10 mg of phenylephrine HCl as a nasal decongestant. The product is formulated without an antihistamine, which differentiates it from some nighttime or multi-symptom formulations that add sedating ingredients.

Haleon’s label instructions typically limit use to no more than 3 packets in 24 hours and no more than 7 days unless directed by a doctor, reflecting standard US over-the-counter practice for combination cold medicines. Pharmacists such as Dr. Michael Ganio, who has commented publicly on combination cold products, often remind consumers to track their total acetaminophen intake across all medicines to avoid exceeding the widely cited 4,000 mg daily limit used in US guidance.

US shelf presence and pricing

In the US, Theraflu Daytime Severe Cold & Cough packets are widely available through mass retailers and pharmacies including Walmart, Target, CVS, and Walgreens, usually shelved alongside branded cold-and-flu sachets and house brands. A check of Walmart’s online listing showed a 6-count box priced in the roughly $7 to $9 range, depending on promotions and region, which places the brand slightly above many store-brand generics but below premium multi-dose formats.

At Target, the product often appears in 6- or 12-count boxes with seasonal discounts in late fall and winter, when retailers push cold products into endcaps and promotional displays. Shopper data from market researchers like IRI and Nielsen, frequently cited in OTC industry coverage, has indicated that US consumers are willing to pay modest brand premiums for cold formulations that promise fast relief and clear symptom coverage, especially in packet or liquid formats that feel easier on a sore throat than solid tablets.

Position in Haleon’s cold portfolio

Theraflu is one of Haleon’s flagship cold brands globally, but Daytime Severe Cold & Cough is just one node in a matrix of Theraflu variants tailored to different symptoms and markets. In the US, Haleon also promotes nighttime versions with antihistamines and different flavors, as well as caplets and syrups under the same Theraflu umbrella, giving retailers an entire shelf block to dedicate to the brand.

Haleon, led by CEO Brian McNamara, has repeatedly described its strategy as focused on consumer health brands with strong medical backing and recognizable names in key categories such as pain, oral care, and respiratory relief. Theraflu sits alongside Advil, Centrum, and Sensodyne in that portfolio, giving the company a cross-category presence in US drugstore aisles and helping it negotiate prominent displays during peak illness seasons.

Consumer experience and product format

From a consumer’s point of view, the powder packet format is as much about ritual as it is about pharmacology. You tear the top of the foil sachet, the fine yellowish powder drops into the mug in a soft cloud, and the steam that rises once you add hot water brings a distinct citrus aroma that signals “cold medicine” even before the first sip. That sensory experience is one reason many US consumers choose Theraflu over capsules when they feel chilled and congested.

US product reviewers on sites like Amazon and Walmart frequently mention the warmth and taste of the drink, sometimes noting that the flavor is strong but tolerable, and that the heat itself feels soothing on a raw throat. A small number of reviewers complain the taste is too intense or that they prefer tablets, underscoring that the packet format is not universally favored but has a clear niche among consumers who want comfort and symptom relief in the same product.

Regulation, labeling, and safety

Like other US over-the-counter cold medicines, Theraflu Daytime Severe Cold & Cough is regulated under the FDA’s OTC monograph frameworks that define acceptable active ingredients, dosage ranges, and required warning statements. The Drug Facts panel on Theraflu’s US packaging includes liver warnings associated with acetaminophen, cautions about using other products containing acetaminophen, and guidance against use in patients with certain chronic conditions unless directed by a doctor.

Dextromethorphan and phenylephrine, the other two active ingredients, also carry standardized warnings, including cautions about combining with certain antidepressants or taking the product if the consumer has heart disease or high blood pressure. US pharmacists such as Dr. Sandra Leal have publicly emphasized that while OTC cold medicines are widely used, consumers still need to read labels carefully, especially when stacking products or taking medication over several days.

Competition on the US cold shelf

Theraflu Daytime Severe Cold & Cough competes directly with powder and liquid brands like P&G’s Vicks DayQuil, Johnson & Johnson’s Tylenol Cold, and various private-label hot drink mixes sold by major chains. In many US stores, Theraflu’s distinctive yellow and green color palette and its emphasis on hot drink relief allow the brand to stand out visually from pill bottles and blister packs on the shelf.

Analysts covering the consumer health sector have noted that cold-and-flu sales can swing considerably from one season to the next, depending on the severity of viral waves, consumer behavior, and timing of promotions. During milder flu seasons, Haleon’s cold brands may see slower growth, whereas strong viral seasons can boost demand for combination products such as Theraflu packets, particularly when health systems encourage people to stay home and self-manage milder symptoms.

Investor angle and OTC focus

For US retail investors, Theraflu Daytime Severe Cold & Cough is a small but visible example of Haleon’s positioning as a pure-play consumer health company following its separation from GSK. While no single cold product moves the needle on its own, a collection of branded OTCs across multiple categories gives Haleon recurring revenue streams that are relatively resilient compared with prescription drug cycles. Haleon PLC stock (NYSE: HLN) is traded in US dollars, and the broader Theraflu line is among the assets that support its respiratory and cold portfolio, though the stock reflects global performance rather than the trajectory of one drink mix.

Key facts on Theraflu Daytime Severe Cold & Cough

• Product: Theraflu Daytime Severe Cold & Cough powder packets
• Manufacturer: Haleon PLC
• Category: Accessories & components (OTC cold remedy format)
• Launch: Marketed in the US as part of the Theraflu line; individual variant updates and packaging refreshes have occurred over multiple cold seasons.
• MSRP / Price: Typically around USD 7–9 for a 6-count box at major US retailers, subject to promotions and regional pricing.
• Availability: Widely sold in the US through pharmacies, mass retailers, and online platforms, including Walmart, Target, CVS, Walgreens, and Amazon.
• Target audience: Adults and children 12+ seeking multi-symptom daytime relief from fever, headache, cough, and nasal congestion in a warm drink format.
• Standout / USP: Combination of three actives in a single-serve powder packet that dissolves in hot water, delivering both symptom relief and a warm, citrus-flavored drink experience.

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.